Christina Rossi - Net Worth and Insider Trading
Christina Rossi Net Worth
The estimated net worth of Christina Rossi is at least $6 Million dollars as of 2024-11-10. Christina Rossi is the CHIEF OPERATING OFFICER of Blueprint Medicines Corp and owns about 64,306 shares of Blueprint Medicines Corp (BPMC) stock worth over $6 Million. Details can be seen in Christina Rossi's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Christina Rossi has not made any transactions after 2024-03-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Christina Rossi
Christina Rossi Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Christina Rossi owns 2 companies in total, including Blueprint Medicines Corp (BPMC) , and Xilio Therapeutics Inc (XLO) .
Click here to see the complete history of Christina Rossi’s form 4 insider trades.
Insider Ownership Summary of Christina Rossi
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BPMC | Blueprint Medicines Corp | 2024-03-07 | Chief Commercial Officer |
| XLO | Xilio Therapeutics Inc | 2021-10-21 | director |
Christina Rossi Latest Holdings Summary
Christina Rossi currently owns a total of 1 stock. Christina Rossi owns 64,306 shares of Blueprint Medicines Corp (BPMC) as of March 7, 2024, with a value of $6 Million.
Latest Holdings of Christina Rossi
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BPMC | Blueprint Medicines Corp | 2024-03-07 | 64,306 | 100.83 | 6,483,974 |
Holding Weightings of Christina Rossi
Christina Rossi Form 4 Trading Tracker
According to the SEC Form 4 filings, Christina Rossi has made a total of 7 transactions in Blueprint Medicines Corp (BPMC) over the past 5 years, including 0 buys and 7 sells. The most-recent trade in Blueprint Medicines Corp is the sale of 6,070 shares on March 7, 2024, which brought Christina Rossi around $550,488.
Insider Trading History of Christina Rossi
- 1
Christina Rossi Trading Performance
Christina Rossi Ownership Network
Ownership Network List of Christina Rossi
Ownership Network Relation of Christina Rossi
Christina Rossi Owned Company Details
What does Blueprint Medicines Corp do?
Who are the key executives at Blueprint Medicines Corp?
Christina Rossi is the Chief Commercial Officer of Blueprint Medicines Corp. Other key executives at Blueprint Medicines Corp include President & R and D Fouad Namouni , director & CEO & President Jeffrey W. Albers , and Principal FAO Michael Landsittel .
Blueprint Medicines Corp (BPMC) Insider Trades Summary
Over the past 18 months, Christina Rossi made no insider transaction in Blueprint Medicines Corp (BPMC). Other recent insider transactions involving Blueprint Medicines Corp (BPMC) include a net sale of 165,808 shares made by Jeffrey W. Albers , a net sale of 38,146 shares made by Michael Landsittel , and a net sale of 14,415 shares made by Ariel Hurley .
In summary, during the past 3 months, insiders sold 27,744 shares of Blueprint Medicines Corp (BPMC) in total and bought 0 shares, with a net sale of 27,744 shares. During the past 18 months, 464,866 shares of Blueprint Medicines Corp (BPMC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 464,866 shares.
Blueprint Medicines Corp (BPMC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Blueprint Medicines Corp Insider Transactions
Christina Rossi Mailing Address
Above is the net worth, insider trading, and ownership report for Christina Rossi. You might contact Christina Rossi via mailing address: 45 Sidney Street, Blueprint Medicines Corporation, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
